Leukotrienes as therapeutic target in asthma (Q40383957)

20 September 2017

1 reference

title

Leukotrienes as therapeutic target in asthma (English)

1 reference

20 September 2017

Pauwels RA

1

1 reference

20 September 2017

Joos GF

series ordinal

2

1 reference

20 September 2017

Kips JC

series ordinal

3

1 reference

20 September 2017

publication date

1 August 1995

1 reference

20 September 2017

1 reference

20 September 2017

volume

50

1 reference

20 September 2017

issue

8

1 reference

20 September 2017

page(s)

615-622

1 reference

Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

A specific LTD4/LTE4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Role of leukotrienes in exercise-induced asthma. Inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

The effect of aerosolized SK&F 104353-Z2 on the bronchoconstrictor effect of leukotriene D4 in asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Effects of inhaled leukotriene D4 and platelet-activating factor on airway reactivity in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Release of leukotrienes in patients with bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Transcellular biosynthesis of leukotrienes and lipoxins via leukotriene A4 transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Potent leukotriene D4 receptor antagonist ICI 204,219 given by the inhaled route inhibits the early but not the late phase of allergen-induced bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

The potential roles of leukotrienes in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Leukotriene D4 receptor blockade inhibits the immediate and late bronchoconstrictor responses to inhaled antigen in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). A double-blind study versus disodium cromoglycate and placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Elevated levels of leukotriene C4 in bronchoalveolar lavage fluid from atopic asthmatics after endobronchial allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

Leukotrienes are potent constrictors of human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.1995.TB02578.X

10.1111/J.1398-9995.1995.TB02578.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference